ACPRF yields 1801.80% · JNJ yields 2.14%● Live data
📍 ACPRF pulled ahead of the other in Year 1
Combined, ACPRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ACPRF + JNJ for your $10,000?
ArcPacific Resources Corp. engages in the identification, evaluation, and acquisition of mineral properties in Canada. It explores for tungsten, copper, silver, lead, zinc, gold, and molybdenum deposits. The company owns 100% interest in the Lucky Mike Silver Lode mineral property covering an area of 8,151 hectares located in the Nicola Mining Division, British Columbia. It also holds 100% interest in the Rickard Gold Mine project that covers an area of 56.65 square kilometers located in Ontario; the Blackdome project covering an area of 3,479 hectares; the Mine Property adjacent to the Rickard gold; and the Three Crown Patents land parcels covering an area of 500 acres. The company has an option agreement to acquire a 100% interest in the TL Nickel Project located in the Churchill Province of Labrador. The company was formerly known as Plate Resources Inc. and changed its name to ArcPacific Resources Corp. in December 2016. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.
Full ACPRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.